RxDoctor Payments Data

William Corder, MD

Allergy & Immunology · Morgantown, WVNPI 1154306850

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 29.5% of the total.

$1,748in general payments, 2019–2025

Across 61 payments — averaging $28.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$516
  • AstraZeneca$442
  • AbbVie$204
  • Genentech USA, Inc.$171
  • Sanofi$106
  • Amgen$72
  • plus $236 from 9 others

What the payments were for

  • Food & beverage$1,748100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few allergy & immunology providers in West Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$23,191
Medicare patients
115
Services billed
1,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SymbicortBudesonide/Formoterol Fumarate18$9,553
Fluticasone-SalmeterolFluticasone Propion/Salmeterol38$6,748
Arnuity ElliptaFluticasone Furoate16$5,693
Epinephrine16$4,274
Azelastine Hcl137$3,802
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$3,218
Fluticasone Propionate102$2,145
Montelukast Sodium115$1,287
Levocetirizine Dihydrochloride71$1,267
Albuterol Sulfate HfaAlbuterol Sulfate43$1,039
Ipratropium Bromide12$540
Hydroxyzine Hcl51$518
Famotidine27$155
Solu-MedrolMethylprednisolone Sod Succ/Pf12$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaSymbicort$442$9,55318 claims
GSKArnuity Ellipta$24$5,69316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy & immunology providers in West Virginiaon file to place this against a meaningful peer group, so we don't.

Other allergy & immunology in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →